Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Inflation Reduction Act; Going Solar is the Next Viral Housing Trend

The newly passed Inflation Reduction Act provides a litany of incentives for homeowners to transition to renewable energies GeoSolar Technologies SmartGreen(TM) package uses leading edge solar, geothermal and air quality technologies to maximize home efficiency with minimal environmental impact GeoSolar’s process is an end-to-end solution to help people better understand all the incentives available and […]

LQwD FinTech Corp. (TSX.V: LQWD) (OTCQB: LQWDF) Leverages Lightning Network to Facilitate Micropayments Across 17 Countries

LQwD’s BTC capacity on The Lightning Network exceeds 30 BTC with over 300 payment channels operating across 17 countries with plans to expand to 24 countries by the end of the current quarter The debut of Bitcoin occurred during the recession of 2008 by an anonymous individual or group later named “Satoshi Nakamoto” The fractionalized […]

DGE 3rd Clinical Trial Agreement Forum to Discuss Important Changes Impacting CTA’S and Remote Monitoring Agreements

Professionals and executives of biopharma and medical device companies are invited to attend DGE’s 3rd Clinical Trial Agreement Forum, a virtual online livestream event, on September 29-30, 2022. The conference will discuss how the evolution of the virtual clinical trial landscape requires flexibility when designing and modifying clinical trial agreements (“CTAs”). Clinical trials have seen many […]

Correlate Infrastructure Partners Inc. (CIPI), a Driver of Highly Cost-effective Solutions for Energy Use Optimization, Sees Significant Revenue Growth in Q2 2022

Correlate posts significant increase in Q2 revenue from $1,584 in 2021 to $236,690 in 2022 Customer deposits have also increased, from $0 during the same period in 2021 to $1,114,154 in Q2 2022, while operating expenses have grown from $4,937 to $1,444,794 Correlate has attributed the growth to the increased emphasis on commercialization, a shift […]

$4M Investment Provides Capital Injection for FingerMotion Inc. (NASDAQ: FNGR) Mobile Device Protection Strategy in China

New York-based institutional fund manager The Lind Partners has reached an investment agreement with mobile device technology innovator FingerMotion Inc. to provide FingerMotion $4 million that will advance its initiatives FingerMotion is focused on varied initiatives for serving China’s massive mobile device user market, its top priority being the rollout of an AppleCare-similar device protection […]

Odyssey Health, Inc. (ODYY) Continues to Report Positive Results from Ongoing Phase I Clinical Trial Evaluating Safety, Efficacy of PRV-002 Concussion Drug Candidate

Odyssey Health is a medical company focused on developing unique, life-saving medical products that offer clinical advantages for unmet clinical needs Recently, the company reported positive results from Cohort I of its Multi-Day Ascending Dosing (“MAD”) portion of its Phase I clinical trial, coming weeks after the successful completion of Phase I Single Ascending Dosing […]

NECANN 3rd Annual New Jersey Cannabis Convention Brings the East Coast Cannabis Community under One Roof

The NECANN Conference has evolved into the largest conference on the East Coast, attracting cannabis cultivators, traders, regulators, lawmakers, and enthusiasts, from the East Coast and beyond. The 3rd annual New Jersey Cannabis Convention is being held from September 9-10, 2022, in Atlantic City, New Jersey. This is a well-curated event organized by a highly […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Delighted About Well-Received DehydraTECH-CBD Proposals by the FDA; Maintains Late 2022/Early 2023 Target For Complete IND Application

Lexaria’s successful HYPER-H21-2 human clinical study, whose results were announced in the first week of September 2021, laid the groundwork for the company’s patented DehydraTECH(TM)-processed CBD NDA Chris Bunka, the company’s CEO, referred to the results as “statistically significant,” ultimately kickstarting the IND application process with the FDA Lexaria has since received a full written […]

DGE 2nd Omnichannel Marketing Strategy Symposium

Life science professionals are invited to attend the 2nd Omnichannel Marketing Strategy Symposium on September 29-30, 2022. Pharmaceutical, biotechnology, and medical device companies are realizing the growing importance of a powerful omnichannel marketing campaign that allows pharma to reach the right people at the right time. This intensifies the need for a substantial marketing plan. […]

 

From Our Blog

Forward Industries Inc. (NASDAQ: FWDI) Is Building the World’s Largest Solana Treasury Company

January 14, 2026

Forward Industries (NASDAQ: FWDI) is a company that continues to compile a large-scale Solana treasury. The strategy for FWDI centers on not only acquiring more SOL, but also actively participating within the ecosystem by deploying assets in opportunities like staking, lending, and DeFi. The company has developed and is applying a rigorous institutional risk management […]

Rotate your device 90° to view site.